Aurobindo Pharma receives USFDA Approval for Entacapone Tablets

22 Jun 2015 Evaluate

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Entacapone Tablets USP, 200mg (ANDA 203437). The product will be launched soon. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Comtan Tablets 200mg of Orion Corporation.

Entacapone Tablets are used in the treatment of Parkinson's disease and has an estimated market size of US$59 Million for the twelve months ending April 2015 according to IMS. This is the 39th ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-betalactam products. 

Aurobindo Pharma Share Price

1191.60 13.40 (1.14%)
17-Dec-2025 14:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.70
Dr. Reddys Lab 1269.70
Cipla 1493.90
Zydus Lifesciences 917.35
Lupin 2107.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×